Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

    DRUG DEVELOPMENT SUPPORT FOR THE CANCER THERAPY EVALUATION PROGRAM

    Sol. 75N91021R00043PresolicitationROCKVILLE, MD
    Closed
    STATUS
    Closed
    closed Oct 13, 2021
    POSTED
    Sep 28, 2021
    Publication date
    NAICS CODE
    541715
    Primary industry classification
    PSC CODE
    Product & service classification

    AI Summary

    The National Institutes of Health is announcing a presolicitation for drug development support related to the Cancer Therapy Evaluation Program. This is a notice of intent, not a request for proposal, and a solicitation will be issued at a later date.

    Contract details

    Solicitation No.
    75N91021R00043
    Notice Type
    Presolicitation
    Posted Date
    September 28, 2021
    Response Deadline
    October 13, 2021
    NAICS Code
    541715AI guide
    Issuing Office
    NIH NCI
    State
    MD
    ZIP Code
    20852
    AI Product/Service
    service

    Description

    THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR PROPOSAL. A SOLICITATION WILL BE ISSUED ON A LATER DATE.

    This synopsis follows a Sources Sought Notice that was posted on May 11, 2021 as HHS-NIH-NCI-SBSS-ETSB-00043-16 with responses d

    Key dates

    1. September 28, 2021Posted Date
    2. October 13, 2021Proposals / Responses Due

    AI search tags

    Frequently asked questions

    DRUG DEVELOPMENT SUPPORT FOR THE CANCER THERAPY EVALUATION PROGRAM is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.